China Outpaces U.S. in AI and Biotech Drug Approvals Amid Regulatory and Operational Drag

China is surpassing the United States in critical technology sectors, notably in artificial intelligence and biotechnology. Recent reports highlight that China is outpacing the U.S. in biotech drug approvals, with experts attributing America's slower progress to regulatory and operational challenges. This growing technological gap extends beyond AI, as China gains a competitive edge in biotech innovation and development.